Public, NASDAQ:HALO
NASDAQ Global Market
Halozyme's Pegylated Enzyme Found to Be Effective in Preclinical Studies
Date: Thu, 24 Jul 2008 20:32:31 GMT
Tags:
Halozyme's Pegylated Enzyme Found to Be Effective in Preclinical Studies
RedOrbit - 15 hours ago
RedOrbit - 15 hours ago
US - based biotechnology company Halozyme Therapeutics has reported positive pre - clinical animal efficacy data for its pegylated - rHuPH20 enzyme.The study showed that treatment of hormone ...
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme In Prostate Cancer Models
Date: Wed, 23 Jul 2008 10:13:45 GMT
Tags:
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme In Prostate Cancer Models
Medical News Today (press release) - Jul 23, 2008
Medical News Today (press release) - Jul 23, 2008
Halozyme Therapeutics , Inc . ( Nasdaq : HALO ) , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix , announced the presentation of positive ...
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
Date: Tue, 22 Jul 2008 14:12:46 GMT
Tags:
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
PR Newswire (press release) - Jul 22, 2008
PR Newswire (press release) - Jul 22, 2008
SAN DIEGO , July 22 / PRNewswire - FirstCall / - - Halozyme Therapeutics , Inc . ( NASDAQ : HALO ) , a biopharmaceutical company developing and commercializing products targeting the extracellular ...
Market Report -- In Play (HALO)
Date: Tue, 22 Jul 2008 13:29:20 GMT
Tags:
Market Report -- In Play (HALO)
MSN Money - Jul 22, 2008
MSN Money - Jul 22, 2008
Halozyme Therapeutics announces ' positive ' findings with pegylated enzyme in prostate cancer models Co announces the presentation of positive pre - clinical animal efficacy data for its pegylated ...
Halozyme Therapeutics Inc (HALO) holdings reduced by Cowen And Company Llc
Date: Wed, 16 Jul 2008 12:55:37 GMT
Tags:
Halozyme Therapeutics Inc (HALO) holdings reduced by Cowen And Company Llc
Mffais.com - Jul 16, 2008
Mffais.com - Jul 16, 2008
LONG BEACH ( Mffais . com ) - Cowen And Company Llc sold - 5,000 ( - 7.88 % ) of their shares in Halozyme Therapeutics Inc ( HALO ) , bringing their current holdings to 58,400 shares as shown ...
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models (PR Newswire)
Date: Tue, 22 Jul 2008 12:00:00 Etc/GMT
Tags:
Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the presentation of positive pre-clinical animal efficacy data for its pegylated-rHuPH20 enzyme at the American Association for Cancer Research Translational Cancer Medicine meeting in Monterey, CA.
The Guru's Corner: Five biotech buys (at MarketWatch)
Date: Thu, 17 Jul 2008 15:49:00 Etc/GMT
Tags:
As the market attempts to put in a near-term bottom, one of the beneficiaries of the rally could be biotechs. They held up very well in the market decline and look strong, not only technically but also fundamentally, with many new drugs in the pipeline.
6 Stocks Defying the Doubters (at Motley Fool)
Date: Thu, 10 Jul 2008 19:32:28 Etc/GMT
Tags:
Aladdin Knowledge Systems, Quest Resource and Allscripts Healthcare Solutions lead small-cap volume in pre-market (SmallCapInvestor.com)
Date: Wed, 2 Jul 2008 13:14:47 Etc/GMT
Tags:
Halozyme shares rise as drug meets study goal (AP)
Date: Tue, 1 Jul 2008 22:36:53 Etc/GMT
Tags:
Shares of Halozyme Therapeutics Inc. rose Tuesday after the biotechnology company said its Chemophase drug candidate met safety and tolerability goals in an early-to-midstage study.